A more comprehensive approach to EFGR inhibition was offered by the study conducted by Hou et al (173), which used three-dimensional convolutional neural networks (CNN) with deep transfer learning to predict the treatment response in patients with stage IV lung adenocarcinoma with EGFR mutations. The gene discussed is EGFR; the disease is lung adenocarcinoma.